When the WHI cohort was stratified by HRT use, a statistically significant positive association between PAI-1 (a pro-inflammatory adipokine) and breast cancer risk was found for postmenopausal women who did not use HRT (highest versus lowest quartile: HR 1.71, 95% CI: 1.02, 2.89), but not for postmenopausal women who used HRT (HR 1.17, 95% CI: 0.71, 1.93) [32]. Here, SERPINE1 is linked to breast carcinoma.